Bionano Genomics, Inc. BNGO
0.95 USD +0.01 (+1.29%)
Regular-session close
0.96 +0.01 +0.83%
After hours · Nov 17, 4:42 PM ET
0.946 Day range 0.9699
0.93 52-week range 2.23
- YTD
- -37.77%
- 1 year
- -36.53%
News
defenseworld.net Comparing Codexis (NASDAQ:CDXS) and Bionano Genomics (NASDAQ:BNGO) Bionano Genomics (NASDAQ: BNGO - Get Free Report) and Codexis (NASDAQ: CDXS - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two…
seekingalpha.com Bionano Genomics, Inc. (BNGO) Q3 2026 Earnings Call Transcript Bionano Genomics, Inc. (BNGO) Q3 2026 Earnings Call Transcript
benzinga.com Bionano Genomics Q3 2026 Earnings Call Transcript Bionano Genomics (NASDAQ:BNGO) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…benzinga.com Bionano Genomics Q3 EPS $(0.54) Misses $(0.51) Estimate, Sales $8.276M Miss $8.443M Estimate Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.51) by 8 percent. This is a 66.04 percent increase over losses of…
benzinga.com Bionano Genomics Affirms FY2026 Sales Guidance of $31.000M-$33.000M vs $32.474M Est Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $31.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.474 million estimate.
benzinga.com Bionano Genomics Q3 Sales $8.276M Miss $8.443M Estimate Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $8.276 million which missed the analyst consensus estimate of $8.443 million by 1.98 percent. This is a 12.34 percent increase over sales of…
globenewswire.com Bionano Reports Third Quarter 2026 Results and Provides a Business Update Conference call today, November 10, 2026, at 4:30 PM ET SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended…
globenewswire.com Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026 SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, November 10, 2026, at 4:30 p.m.…
globenewswire.com Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies SAN DIEGO, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs),…
globenewswire.com Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia Independent research teams at MD Anderson Cancer Center, the University of Oulu, and the Josep Carreras Leukaemia Research Institute report that optical genome mapping (OGM) uncovers clinically…
globenewswire.com Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs),…
globenewswire.com Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping New York State Department of Health approval allows clinical use of optical genome mapping (OGM) based lab developed tests (LDTs) for patients with suspected genetic disease, reproductive disorders,…
globenewswire.com Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that management will present and host 1x1 meetings at the H.C. Wainwright 28th Annual Global…
seekingalpha.com Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript
globenewswire.com Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, August 10, 2026, at 4:30 p.m.…
globenewswire.com Bionano Announces Hiring of Chief Scientific Officer SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief…
globenewswire.com Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics…
globenewswire.com Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders SAN DIEGO, June 11, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that to date in 2026, a total of 13 studies analyzing 730 samples were published with key findings that…
zacks.com Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? Bionano Genomics (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zacks.com Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors Bionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are…
globenewswire.com Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has fully retired and cancelled all outstanding Senior Secured Convertible Debentures (the…
globenewswire.com Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced publication of a peer-reviewed study in Modern Pathology showing that optical genome mapping (OGM)…
seekingalpha.com Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call Transcript Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call Transcript
zacks.com Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to a loss of $1.15 per share a year ago.
